According to Novocure 's latest financial reports the company's current revenue (TTM) is $0.50 B. In 2022 the company made a revenue of $0.53 B an increase over the years 2021 revenue that were of $0.53 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2023 (TTM) | $0.50 B | -5.3% |
2022 | $0.53 B | 0.53% |
2021 | $0.53 B | 8.23% |
2020 | $0.49 B | 40.72% |
2019 | $0.35 B | 41.62% |
2018 | $0.24 B | 40.13% |
2017 | $0.17 B | 113.57% |
2016 | $82.88 M | 150.52% |
2015 | $33.08 M |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
Organovo ONVO | $0.24 M | -99.95% | ๐บ๐ธ USA |
Orchard Therapeutics
ORTX | $21.83 M | -95.71% | ๐ฌ๐ง UK |
Novavax NVAX | $0.69 B | 36.15% | ๐บ๐ธ USA |
Novocure
NVCR | $0.50 B | 0.00% | Jersey |